BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aslam S, Danziger-Isakov L, Mehra MR. COVID-19 vaccination immune paresis in heart and lung transplantation. J Heart Lung Transplant 2021;40:763-6. [PMID: 34144891 DOI: 10.1016/j.healun.2021.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Costard-Jäckle A, Schramm R, Fischer B, Rivinius R, Bruno R, Müller B, Zittermann A, Boeken U, Westenfeld R, Knabbe C, Gummert J. Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response. Clin Res Cardiol 2022. [PMID: 35994091 DOI: 10.1007/s00392-022-02075-2] [Reference Citation Analysis]
2 Peled Y, Patel JK, Afek A, Mandelboim M. Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant: Correspondence. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.012] [Reference Citation Analysis]
3 Gallais F, Renaud-picard B, Solis M, Laugel E, Soulier E, Caillard S, Kessler R, Fafi-kremer S. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.008] [Reference Citation Analysis]
4 Altneu E, Mishkin A. COVID-19 Vaccination in Lung Transplant Recipients. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-022-01364-9] [Reference Citation Analysis]
5 Shaul AA, Itzhaki Ben Zadok O, Ben-Avraham B, Yaari V, Barsheshet A, Levi A, Ben Zvi H, Eliakim Raz N, Abed G, Abuhazira M, Abu Akel M, Mats I, Barac YD, Aravot D, Kornowski R, Ben-Gal T. Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients. Eur J Cardiothorac Surg 2022:ezac145. [PMID: 35244690 DOI: 10.1093/ejcts/ezac145] [Reference Citation Analysis]
6 Dhand A, Razonable RR. COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00357-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Hogan JI, Kotton CN. A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient. Open Forum Infect Dis 2021;8:ofab557. [PMID: 34988243 DOI: 10.1093/ofid/ofab557] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tanner R, Starr N, Chan G, Dempsey E, Heffernan E, Newman E, O'neill J, Hannan MM, Lynch B, Joyce E. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zheng Y, Shen P, Xu B, Chen Y, Luo Y, Dai Y, Hu Y, Zhou YH. COVID-19 vaccination coverage among healthcare workers in obstetrics and gynecology during the first three months of vaccination campaign: a cross-sectional study in Jiangsu province, China. Hum Vaccin Immunother 2021;:1-8. [PMID: 34802373 DOI: 10.1080/21645515.2021.1997297] [Reference Citation Analysis]
10 Dębska-Ślizień A, Ślizień Z, Muchlado M, Kubanek A, Piotrowska M, Dąbrowska M, Tarasewicz A, Chamienia A, Biedunkiewicz B, Renke M, Tylicki L. Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study-The COViNEPH Project. Vaccines (Basel) 2021;9:1165. [PMID: 34696273 DOI: 10.3390/vaccines9101165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Peled Y, Ram E, Lavee J, Segev A, Matezki S, Wieder-Finesod A, Halperin R, Mandelboim M, Indenbaum V, Levy I, Sternik L, Raanani E, Afek A, Kreiss Y, Lustig Y, Rahav G. Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience. J Heart Lung Transplant 2021:S1053-2498(21)02481-5. [PMID: 34565682 DOI: 10.1016/j.healun.2021.08.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 39.0] [Reference Citation Analysis]
12 Hallett AM, Greenberg RS, Boyarsky BJ, Shah PD, Ou MT, Teles AT, Krach MR, López JI, Werbel WA, Avery RK, Bae S, Tobian AA, Massie AB, Higgins RSD, Garonzik-Wang JM, Segev DL, Bush EL. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant 2021:S1053-2498(21)02445-1. [PMID: 34456108 DOI: 10.1016/j.healun.2021.07.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Magicova M, Fialova M, Zahradka I, Rajnochova-Bloudickova S, Hackajlo D, Raska P, Striz I, Viklicky O. Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients. Am J Transplant 2021. [PMID: 34212497 DOI: 10.1111/ajt.16746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]